| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |